A Phase II Study of the Combination of Aflibercept (VEGF-Trap) Plus Modified FOLFOX 6 in Patients With Previously Untreated Metastatic Colorectal Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 02 Feb 2017
At a glance
- Drugs Aflibercept (Primary) ; Fludeoxyglucose F-18; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 14 Oct 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Sep 2017.
- 15 Jul 2016 Status changed from recruiting to active, no longer recruiting.